Monterey Bio Acquisition Corp Overview
Industry: Investment Holding Companies
Sector: Financials
Monterey Bio Acquisition Corporation does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses in the biotech industry. The company was formerly known as Chardan FinTech Acquisition Corp. and changed its name to Monterey Bio Acquisition Corporation in April 2021. Monterey Bio Acquisition Corporation was incorporated in 2020 and is based in New York, New York.
Monterey Bio Acquisition Corp is evaluated using Mavefund's quality framework: growing earnings, durable profit margins, conservative leverage, strong return on equity, and disciplined share repurchases.
Score
Price History & Performance
Review Monterey Bio Acquisition Corp in context before unlocking the interactive price chart, financial overlays, and downloadable ratio tables.
Recent News
Monterey Bio Acquisition Corp Competitors
Monterey Bio Acquisition Corp operates in the Investment Holding Companies industry within the Financials sector. Unlock the full page to compare peer rankings, valuation quality, profitability, leverage, and growth trends.
Earnings Per Share
EPS quality is one of the core Mavefund signals. Sign up to continue into the detailed EPS, ROE, margin, share buyback, leverage, and financial ratio analysis.
Continue the analysis
Sign up to unlock ROE, net margin, share buyback, leverage, financial ratios, peer charts, and downloads.
View plans